Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonates in renal osteodystrophy.

S L Fan1, J Cunningham

  • 1Department of Nephrology, St Bartholomew's and The Royal London Hospitals, London, UK. stanley.fan@virgin.net

Current Opinion in Nephrology and Hypertension
|August 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Online Learning to Support Culturally Safe Communication with First Nations Australians in Radiation Therapy: A Pre-Post Intervention Study.

Cancer control : journal of the Moffitt Cancer Center·2026
Same author

Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop.

Basic research in cardiology·2024
Same author

Patterns of pain medication usage and self-reported pain in older Irish adults with osteoarthritis: A latent class analysis of data from the Irish Longitudinal Study on Ageing.

BMC musculoskeletal disorders·2024
Same author

Development of the What Matters 2 Adults (WM2A) wellbeing measure for Aboriginal and Torres Strait Islander adults.

Social science & medicine (1982)·2024
Same author

[Effect of early rehabilitation training on motor function and neural function of patients with brainstem hemorrhage after body-oriented individualized surgery].

Zhonghua yi xue za zhi·2023
Same author

[Preclinical evaluation of a veno-venous bypass device for liver transplantation based on the principle of magnetic levitation drive].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2022
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
See all related articles

Bisphosphonates may help reduce fracture risk in osteoporosis patients with kidney problems. However, their use in renal osteodystrophy requires careful consideration due to potential drawbacks.

Area of Science:

  • Nephrology
  • Bone Metabolism
  • Pharmacology

Background:

  • Bisphosphonates are commonly prescribed for osteoporosis to lower fracture risk.
  • Limited research exists on bisphosphonate efficacy and safety in renal osteodystrophy.
  • Bone loss post-renal transplantation and the osteoprotegerin/receptor activating nuclear factor-kappaB system are key areas of interest.

Purpose of the Study:

  • To review the potential role of bisphosphonates in patients experiencing renal failure.
  • To explore the implications of bisphosphonate use in the context of renal osteodystrophy.
  • To discuss recent findings on bone loss mechanisms and therapeutic targets in kidney disease patients.

Main Methods:

  • Literature review focusing on bisphosphonate use in renal failure.

Related Experiment Videos

  • Analysis of studies on bone loss after renal transplantation.
  • Examination of the osteoprotegerin/receptor activating nuclear factor-kappaB system's role.

    • Main Results:

    • Bisphosphonates may inhibit bone resorption, potentially beneficial in high bone turnover states.
    • Evidence regarding bisphosphonate effectiveness in renal osteodystrophy is scarce.
    • Potential adverse effects and limitations of bisphosphonate therapy in this population warrant consideration.

    Conclusions:

    • Bisphosphonates' role in renal failure patients requires further investigation.
    • Careful patient selection and monitoring are crucial for bisphosphonate use in renal osteodystrophy.
    • The balance between benefits and risks must be weighed, especially considering recent research.